Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleReply to Piccaluga et al.AuthorsLaporte, J-P; Isnard, F; Fouillard, L; Garderet, L; Gorin, N-CAbstractPresents a letter to the editor replying to a comment on a study on the use of alemtuzumad in an adult patient with refractory acute lymphocytic leukemia.SubjectsLETTERS to the editor; LYMPHOCYTIC leukemiaPublicationLeukemia (08876924), 2005, Vol 19, Issue 1, p136ISSN0887-6924Publication typeLetterDOI10.1038/sj.leu.2403579